vimarsana.com

Karolinska Development's portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBC

Card image cap

Karolinska Development's portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBC

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Stockholm , Sweden , Umecrine Cognitions , Viktor Drvota , Karolinska Institutet , Johan Dighed , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Nasdaq Stockholm , Umecrine Cognition , Primary Biliary Cholangitis , General Counsel ,

comparemela.com © 2020. All Rights Reserved.